サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404836

ニコチン置換療法の市場規模、シェア、動向分析レポート：製品別、流通チャネル別、地域別、セグメント予測、2023年～2030年

Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Nicotine Replacement Therapy, E-cigarettes, Heat-not-burn Tobacco Products), By Distribution Channel (Online, Offline), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 82 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ニコチン置換療法の市場規模、シェア、動向分析レポート：製品別、流通チャネル別、地域別、セグメント予測、2023年～2030年
出版日: 2023年11月30日
発行: Grand View Research
ページ情報: 英文 82 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ニコチン置換療法市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のニコチン置換療法市場規模は2030年までに1,987億米ドルに達する見込みです。

2023年から2030年までのCAGRは16.3%で成長すると予測されます。同市場の成長は、喫煙による死亡率やそれに関連する疾患を減らすためにニコチン置換療法（NRT）製品を普及させる政府の取り組みが増加していることが主な要因です。

禁煙キャンペーンも、喫煙が原因で引き起こされる病気についての認識を高める上で重要な役割を果たしています。こうしたキャンペーンは、フィリップ・モリス・インターナショナルやアルトリアといった多国籍企業だけでなく、各地域の政府も実施しています。WHOのような世界の組織も、オンライン・キャンペーンを実施することで、意識の向上に努めています。

NRT製品の使用量は急激に増加しています。若年層は、加熱式タバコや電子タバコのような先進的なNRT製品の最大の消費者です。しかし、中高年患者の禁煙への関心が、電子タバコの使用量の増加につながっています。例えば、45歳から54歳の人々の禁煙のための電子タバコの使用は、2016年の13％から2018年には20％に増加しました。

さらに、喫煙者の5％から9％は、12週間の治療期間後もニコチンパッチを使用する傾向があることが調査により判明しました。ニコチンパッチとガム、吸入器、スプレーを併用する受動的アプローチがより効果的で、禁煙率は34％から54％に達することがわかった。NRTは、ニコチン渇望を抑制し、消費者に治療する方法としてのみ認識されています。

技術の進歩に伴い、この市場のプレーヤーも変化する消費者の嗜好に合わせて製品を開発しています。例えば、電子タバコ市場は、より効率的で、バッテリー寿命が長く、充電可能な新しい技術革新によって変化しています。洗練された使いやすい社会的に受け入れられる電子タバコのような既存の技術革新は革命をもたらし、より多くの人々が社会的烙印を押されることなくNRTを使用するようになりました。

ニコチン置換療法市場のレポートハイライト

  • 製品別では、投資の増加と付加価値製品の開発に注力する企業の増加により、電子タバコ分野が2022年のNRT市場で最大のシェアを占めました。加熱式非燃焼タバコ製品セグメントは予測期間中最も速い速度で成長すると予想されます。
  • オフライン流通チャネル分野は2022年の市場を独占しました。世界中の小売チェーンは、売上を向上させ、より多くの顧客を引き付けるために、先進技術に投資し、新たな取り組みを行っています。VAPEショップや小売店を通じて電子タバコの販売が増加していることも、このセグメントの成長を増大させる要因となっています。
  • アジア太平洋は2022年に最大の市場シェアを占めました。有利な政府の取り組みと、医薬品に対する償還状況の進化が、継続的な成長を支えています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ニコチン置換療法市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ニコチン置換療法市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 ニコチン置換療法：製品推定・動向分析

  • ニコチン置換療法市場：重要なポイント
  • ニコチン置換療法市場：動向と市場シェア分析、2022年および2030年
  • ニコチン置換療法
    • 吸入器
    • ガム
    • 経皮パッチ
    • 舌下錠
    • トローチ
    • その他
  • 電子タバコ
  • 加熱式タバコ製品

第5章 ニコチン置換療法：流通チャネルの推定・動向分析

  • ニコチン置換療法市場：重要なポイント
  • ニコチン置換療法市場：動向と市場シェア分析、2022年および2030年
  • オンライン
  • オフライン

第6章 ニコチン置換療法市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別のニコチン置換療法市場：主要なマーケットプレース要点
  • 北米
    • 北米市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州市場推計・予測、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • アジア太平洋市場推計・予測、2018～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカ市場推計・予測、2018～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • MEA市場推計・予測、2018年から2030年
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • Cipla Inc.
    • Pfizer Inc.
    • GLENMARK PHARMACEUTICALS LTD.
    • Fertin Pharma
    • Philip Morris Products S.A.
    • British American Tobacco plc
    • Japan Tobacco Inc.
    • Imperial Brands plc
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America nicotine replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 5 U.S. nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 7 Canada nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Europe nicotine replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 11 Europe nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 12 Germany nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 14 UK nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 16 France nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 17 France nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 Italy nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20 Spain nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 Sweden nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 23 Sweden nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Norway nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 25 Norway nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26 Denmark nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 27 Denmark nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific nicotine replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 31 China nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 32 China nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 33 Japan nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 34 Japan nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 35 India nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 36 India nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Australia nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 Thailand nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 South Korea nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Latin America nicotine replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 45 Latin America nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 46 Brazil nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48 Mexico nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50 Argentina nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa nicotine replacement therapy market, by region, (USD Million) 2018 -2030
  • Table 53 Middle East and Africa nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 South Africa nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 UAE nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Kuwait nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Pediatric catheters: market outlook
  • Fig. 9 Pediatric catheters competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Nicotine replacement therapy market driver impact
  • Fig. 14 Nicotine replacement therapy market restraint impact
  • Fig. 15 Nicotine replacement therapy market strategic initiatives analysis
  • Fig. 16 Nicotine replacement therapy market: Product movement analysis
  • Fig. 17 Nicotine replacement therapy market: Product outlook and key takeaways
  • Fig. 18 Nicotine replacement therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Gum market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Transdermal patches market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Sublingual tablets market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Lozenges market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 E-cigarettes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Heat-not-burn tobacco products market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Nicotine replacement therapy market: Distribution channel movement analysis
  • Fig. 28 Nicotine replacement therapy market: Distribution channel outlook and key takeaways
  • Fig. 29 Online market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Offline market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Nicotine replacement therapy market: Regional movement analysis
  • Fig. 32 Nicotine replacement therapy market: Regional outlook and key takeaways
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-292-8

Nicotine Replacement Therapy Market Growth & Trends:

The global nicotine replacement therapy market size is expected to reach USD 198.7 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to grow at a CAGR of 16.3% from 2023 to 2030. The growth of the market is largely attributed to increasing government initiatives to promote nicotine replacement therapy (NRT) products for reducing mortality due to smoking and diseases associated with it.

Smoking cessation campaigns are also playing a crucial role in increasing awareness about diseases that are caused because of smoking. These campaigns are run by regional governments as well as multinational companies, such as Philip Morris International and Altria. Global organizations like the WHO are also working toward creating awareness by running online campaigns.

There has been an exponential increase in the usage of NRT products. The young population is the largest consumer of advanced NRT products, like heat-not-burn tobacco and e-cigarettes. However, middle-aged patients' interest in smoking cessation has led to a rise in the usage of e-cigarettes. For instance, the use of e-cigarettes for smoking cessation increased to 20% in 2018 from 13% in 2016 among people aged 45 to 54 years.

Furthermore, researchers found that 5% to 9% of smokers tend to use nicotine patches even after the therapeutic period of 12 weeks. The passive approach of combining nicotine patches with a gum, inhaler, or spray is found to be more effective, and quitting rate reaching 34% to 54%. NRT is only recognized as a way of curbing nicotine cravings and treatment by consumers.

With technological advancements, the players in this market are also developing products to suit the changing consumer preferences. For instance, the e-cigarette market is changing with newer innovations that are more efficient, have longer battery life, and are rechargeable. The existing innovations like sleek and easy-to-use socially acceptable e-cigarettes brought a revolution, which drove more people to shift to using NRTs without social stigma.

Various players such as Nicocigs Ltd.; Nicoventures Ltd.; Victory Electronic Cigarettes Corp.; DuraSmoke; AlternaCig; Shenzhen IVPS Technology CO. Limited; and Vapor Group, Inc. are launching e-cigarettes and related products. Although there are hundreds of companies selling e-cigarettes, their usage in NRT is disputed.

Nicotine Replacement Therapy Market Report Highlights:

  • By product, the e-cigarettes segment held the largest NRT market share in 2022 due to increasing investments and the rising focus of companies on developing value-added products. The heat-not-burn tobacco products segment is expected to grow at the fastest rate over the forecast period
  • The offline distribution channel segment dominated the market in 2022. Retail chains across the world are investing in advanced technologies and undertaking new initiatives in order to improve sales and attract more customers. The increasing sales of e-cigarettes through vape shops and retail stores is another factor augmenting the growth of this segment
  • Asia Pacific held the largest market share in 2022. Favorable government initiatives, coupled with an evolving reimbursement landscape for pharmaceutical products, are supporting continual growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Distribution channel
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Distribution channel outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Nicotine Replacement Therapy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Nicotine Replacement Therapy Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Pediatric Catheters: Product Estimates & Trend Analysis

  • 4.1. Nicotine Replacement Therapy Market: Key Takeaways
  • 4.2. Nicotine Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Nicotine Replacement Therapy
    • 4.3.1. Nicotine replacement therapy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Inhalers
      • 4.3.2.1. Inhalers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Gum
      • 4.3.3.1. Gum market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Transdermal patches
      • 4.3.4.1. Transdermal patches market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Sublingual tablets
      • 4.3.5.1. Sublingual tablets market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.6. Lozenges
      • 4.3.6.1. Lozenges market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. E-cigarettes
    • 4.4.1. E-cigarettes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Heat-not-burn tobacco products
    • 4.5.1. Heat-not-burn tobacco products market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Pediatric Catheters: Distribution Channel Estimates & Trend Analysis

  • 5.1. Nicotine Replacement Therapy Market: Key Takeaways
  • 5.2. Nicotine Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Online
    • 5.3.1. Online market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Offline
    • 5.4.1. Offline market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Nicotine Replacement Therapy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Nicotine Replacement Therapy Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. UK
      • 6.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. France
      • 6.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. China
      • 6.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. India
      • 6.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Cipla Inc.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Pfizer Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. GLENMARK PHARMACEUTICALS LTD.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Fertin Pharma
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Philip Morris Products S.A.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. British American Tobacco plc
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Japan Tobacco Inc.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Imperial Brands plc
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Johnson & Johnson Private Limited
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives